NIH, Gates Foundation Announce At Least $200M Investment Over 4 Years To Develop Affordable Gene-Based Therapies For Sickle Cell Disease, HIV
STAT: NIH and Gates Foundation launch effort to bring genetic cures for HIV, sickle cell disease to world’s poor
“The National Institutes of Health and the Bill and Melinda Gates Foundation will together invest at least $200 million over the next four years to develop gene-based cures for sickle cell disease and HIV with an attribute even rarer in the world of genetic medicine than efficacy, the groups announced on Wednesday: The cures, they vowed, will be affordable and available in the resource-poor countries hit hardest by the two diseases, particularly in Africa…” (Begley, 10/23).
Additional coverage of the investment is available from AFP and Bloomberg Law.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.